ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 750341 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 750341; 2) Community: the network communities that were significantly associated with the response to NSC 750341; 3) Molecule: the relationships between components within communities and NSC 750341; 4) MDR: the compounds that were significantly associated with the NSC 750341.

NSC Compound Enrichment Correlation
NSC 685285 Null 0.0129421834592789 0.26596869
NSC 688228 Null 0.0129421834592789 0.099576588
NSC 694619 Null 0.0129421834592789 0.19332014
NSC 711077 Null 0.0129421834592789 0.042473043
NSC 718781 Erlotinib hydrochloride 0.0129421834592789 0.16497145
NSC 724783 [1,5-dimethyl-10-(trifluoromethyl)-11,14,15,16-tetraoxatetra cyclo[10.3.1.04,13.08,13]hexadec-9-en-9-yl]-N,N-bis{[1,5-dim ethyl-10-(trifluoromethyl)-11,14,15,16-tetraoxatetracyclo[10 .3.1.04,13.08,13 0.0129421834592789 0.26092607
NSC 726217 Combretastatin A4-analogue 0.0129421834592789 0.30242272
NSC 732205 Null 0.0129421834592789 0.51254152
NSC 732936 5,6-Dihydro-6-(3-dimethylamino-1-propyl)-2,3-methylenedioxy- 5,11-dioxo-11H-indeno[1,2-c]isoquinoline 0.0129421834592789 0.4326959
NSC 732962 5-amino-4-(1,3-benzothiazol-2-yl)-1-(2-chloro-5-trifluoromet hylphenyl)-2,3-dihydro-1H-3-pyrrolone 0.0129421834592789 0.23670688
Total:151  Current:59    [First] [Prev] [Next] [Last]